-
321
Association between atherogenic index of plasma and type 2 diabetic complications: a cross-sectional study
Published 2025-02-01“…BackgroundThe Atherogenic Index of Plasma (AIP) was originally developed primarily as a marker for assessing atherosclerosis. Consequently, this study investigates the potential association between AIP and type 2 diabetic complications through a cross-sectional design.MethodsThe National Metabolic Management Center(MMC) serves as a comprehensive platform dedicated to the establishment of standardized protocols for the diagnosis, treatment, and long-term follow-up of metabolic diseases. …”
Get full text
Article -
322
Annexin V+ Microvesicles in Children and Adolescents with Type 1 Diabetes: A Prospective Cohort Study
Published 2020-01-01“…Type 1 diabetes is a chronic disease including hyperglycemia and accelerated atherosclerosis, with high risk of micro- and macrovascular complications. …”
Get full text
Article -
323
Circulatory Immune Cells in Cushing Syndrome: Bystanders or Active Contributors to Atherometabolic Injury? A Study of Adhesion and Activation of Cell Surface Markers
Published 2017-01-01“…Glucocorticoids (GC) induce cardiometabolic risk while atherosclerosis is a chronic inflammation involving immunity. …”
Get full text
Article -
324
Determinants of Vessel Targeting in Vasculitis
Published 2004-01-01“…This paper will explore the hypothesis that important differences exist in regions of the aorta that determine vulnerability to diseases, such as atherosclerosis, aortitis, giant cell arteritis and Takayasu's disease. …”
Get full text
Article -
325
The Role of Poly(ADP-ribose) Polymerase-1 in Rheumatoid Arthritis
Published 2015-01-01“…In addition to the role of PARP-1 in DNA repair, multiple studies have also demonstrated its involvement in several inflammatory diseases, such as septic shock, asthma, atherosclerosis, and stroke, as well as in cancer. In these diseases, the pharmacological inhibition of PARP-1 has shown a beneficial effect, suggesting that PARP-1 regulates their inflammatory processes. …”
Get full text
Article -
326
Type A Behaviours and Heart Disease: Epidemiological and Experimental Foundations
Published 1990-01-01“…This paper critically examines three strands of evidence that concern the relationship between type A behaviours and coronary heart disease; prospective epidemiological studies of healthy populations, studies of those at high risk for coronary heart disease, and angiographic studies of atherosclerosis. The first of these would seem to provide the strongest test. …”
Get full text
Article -
327
Epidemiology and Etiology of Young Stroke
Published 2011-01-01“…It remains the case, however, that atherosclerosis contributes to a large proportion of stroke in young patients, thus, conventional risk factors must be targeted aggressively.…”
Get full text
Article -
328
Lipophagy: Connecting Autophagy and Lipid Metabolism
Published 2012-01-01“…Defective lipophagy has been already linked to important metabolic disorders such as fatty liver, obesity and atherosclerosis, and the age-dependent decrease in autophagy could underline the basis for the metabolic syndrome of aging.…”
Get full text
Article -
329
The Impact of Incretin-Based Medications on Lipid Metabolism
Published 2021-01-01“…Thus, diabetes is commonly accompanied by varying degrees of dyslipidemia which is itself a major risk factor for further macro- and microvascular diabetes complications such as atherosclerosis and nephropathy. Therefore, normalizing lipid metabolism is an attractive goal for therapy in patients with diabetes. …”
Get full text
Article -
330
Proinflammatory Effects of C-Peptide in Different Tissues
Published 2012-01-01“…Atherosclerosis is well known as an inflammatory disease that can lead to clinical complications such as heart attack or stroke. …”
Get full text
Article -
331
Osteoprotegerin in Cardiometabolic Disorders
Published 2015-01-01“…The association of OPG with diabetic complications (neuropathy, nephropathy, or retinopathy) as well as with atherosclerosis, coronary artery calcification, morbidity, and mortality is pointed out. …”
Get full text
Article -
332
Where Are We Heading with Noninvasive Clinical Vascular Physiology? Why and How Should We Assess Endothelial Function?
Published 2011-01-01“…The first investigations in humans involved invasive pharmacological vascular function testing, which have been used to gain a detailed understanding of the mechanisms involved in the pathogenesis of endothelial dysfunction and atherosclerosis as well as novel targets for intervention. …”
Get full text
Article -
333
Advanced Asymptomatic Carotid Disease and Cognitive Impairment: An Understated Link?
Published 2012-01-01“…Neurosonological methods enable simple and noninvasive assessment of carotid stenosis in patients at risk of advanced atherosclerosis. Cognitive status in patients diagnosed with advanced carotid stenosis is routinely not taken into consideration, although if cognitive impairment is present, such patients should probably be called symptomatic. …”
Get full text
Article -
334
A Whole-Food Plant-Based Diet Reversed Angina without Medications or Procedures
Published 2015-01-01“…Adoption of this form of lifestyle therapy should be among the first recommendations for patients with atherosclerosis.…”
Get full text
Article -
335
Dilating Vascular Diseases: Pathophysiology and Clinical Aspects
Published 2018-01-01“…Mostly, they have been defined as variants of atherosclerosis. Although there are some similarities in terms of pathogenesis, they are distinct from atherosclerotic disease of the vessels. …”
Get full text
Article -
336
Does Hsp60 Provide a Link between Mitochondrial Stress and Inflammation in Diabetes Mellitus?
Published 2016-01-01“…We will also look at the role of Hsp60 during immune cell activation in atherosclerosis, a significant risk factor during the pathogenesis of diabetes mellitus.…”
Get full text
Article -
337
Experience of instantaneous transaction coronary bypass surgery with carotid endarterectomy
Published 2017-09-01“…Based on experience (89 cases with zero lethality and no central nervous system complications), it is recommended to use this treatment approach in patients with atherosclerosis of coronary and brachiocephalic arteries. …”
Get full text
Article -
338
Cardiovascular and Renal Links along the Cardiorenal Continuum
Published 2011-01-01“…The majority of vascular events are caused by accelerated atherosclerosis. Moreover, cardiovascular events rarely occur in patients without underlying disease; rather, they typically take place as the final stage of a pathophysiological process that results in progressive vascular damage, including vital organ damage, specifically the kidney and the heart if these factors are uncontrolled. …”
Get full text
Article -
339
Relationship between Prolactin, Chronic Kidney Disease, and Cardiovascular Risk
Published 2020-01-01“…It has high cardiovascular morbidity and mortality, with traditional risk factors such as atherosclerosis, hypertension, diabetes, smoking, and left ventricular hypertrophy being common. …”
Get full text
Article -
340
β-Endorphin Mediates the Development and Instability of Atherosclerotic Plaques
Published 2020-01-01“…Thus, μ-opioid receptor antagonists may be useful for the prevention and treatment of atherosclerosis.…”
Get full text
Article